RP Investment Advisors’s Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100,000
Closed -$100K 172
2021
Q4
$100K Buy
+100,000
New +$99.2K 0.01% 141

Other funds holding WPCB.WS

RP Investment Advisors's WPCB.WS Position: Q1 2022 in Review

RP Investment Advisors sold out of Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCB.WS) in Q1 2022, closing a stake of 100,000 shares — an estimated $100K sold.

RP Investment Advisors first reported a position in WPCB.WS in Q4 2021 and held it in 1 quarter. The position peaked at $100K in Q4 2021. 51 funds tracked by Wall St. Rank hold WPCB.WS as of Q1 2022.

  • RP Investment Advisors reported no remaining Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • RP Investment Advisors sold 100,000 Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $100K.
  • RP Investment Advisors first reported a position in Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 1 quarter.
  • RP Investment Advisors's Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $100K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on RP Investment Advisors's 13F filing for Q1 2022, filed 16 May 2022.